anti-CD11a antibody product blog
Tags: Antibody; Monoclonal Antibody; CD11a; anti-CD11a antibody;
The CD11a n/a (Catalog #MBS5309224) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. The CD11a antibody reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s CD11a can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA).A standard curve consisting of doubling dilutions of the recombinant standard over the range of 8000 pg/ml-60 pg/ml should be included in each ELISA plate. Researchers should empirically determine the suitability of the CD11a n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the CD11a antibody with the following immunoassay(s):
Flow Cytometry (FC/FACS) (Staining of mouse splenocytes with CD11a antibody (FITC) (left) (PE) (right). Appropriate Isotype Controls were used (open histogram). Total viable cells were used for analysis.)
The M17/4 monoclonal antibody reacts with mouse CD11a, the 180 kDa integrin alphaL, also known as the lymphocyte function associated antigen-1 alpha chain. LFA-1, formed by non-covalent association of CD11a with CD18, serves as an important adhesion molecule involved in lymphocyte and granulocyte function. CD54, CD102, and CD50 are ligands for LFA-1. CD11a is expressed by all leukocytes.
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD11a are readily searchable from our website. Different antibodies against the same target such as CD11a may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.